Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...